Rohan Chaubal
Clinical Scientist, Entreprenuer, Listener.
LinkedIn
LinkedIn
Discord
Discord
Email
Email
Academics
3 items
Get in Touch
Multi-Omics & Liquid Biopsies
Tata Memorial Centre and National Institute of Biomedical Genomics Uncover Genomic Basis of Hormone Therapy Resistance in Breast Cancer
Tata Memorial Centre and National Institute of Biomedical Genomics Uncover Genomic Basis of Hormone Therapy Resistance in Breast Cancer
: Mumbai, February 12, 2025 A groundbreaking study conducted by researchers from Tata Memorial Ce
Researchers find key genomic factors causing hormone therapy resistance in breast cancer
Researchers find key genomic factors causing hormone therapy resistance in breast cancer
New hope for breast cancer patients: Indian study identifies key genetic markers for treatment resistance. Why is it significant?
New hope for breast cancer patients: Indian study identifies key genetic markers for treatment resistance. Why is it significant?
How these findings could help doctors identify patients who are less likely to respond to hormone therapy
x.com
Hotspots, resistant tumours behind 40% failure in breast cancer therapy | Hindustan Times Thane - Newspaper - Read this story on Magzter.com
Hotspots, resistant tumours behind 40% failure in breast cancer therapy | Hindustan Times Thane - Newspaper - Read this story on Magzter.com
Lees dit spannende verhaal uit Hindustan Times Thane February 13, 2025 uitgave. A new multi-institutional study has offered crucial insights into why some patients, both in India and across the world, with the most common sub-type of breast cancer - estrogen receptor positive (ER+) - do not respond or stop responding to hormone therapy, leading to relapse.
स्तनाच्या कर्करोगावरील प्रतिरोधक जीनोमिकांचा शोध; टाटा मेमोरियल सेंटरचा दावा, भारतीय महिलांमध्ये कर्करोगाचे सर्वाधिक प्रमाण
स्तनाच्या कर्करोगावरील प्रतिरोधक जीनोमिकांचा शोध; टाटा मेमोरियल सेंटरचा दावा, भारतीय महिलांमध्ये कर्करोगाचे सर्वाधिक प्रमाण
मुंबई : टाटा मेमोरियल सेंटर-मुंबई, आणि नॅशनल इन्स्टिट्यूट ऑफ बायोमेडिकल जीनोमिक्स, पश्चिम बंगाल येथील संशोधकांनी स्तनाच्या कर्करोगावरील संप्रेरक उपचारांना प्रति
TMC overcomes resistance to hormonal therapy for breast cancer
TMC overcomes resistance to hormonal therapy for breast cancer
Molecular mechanism of hormonal therapy’s protective benefits identified
Deciphering progesterone’s mechanisms of action in breast cancer
Deciphering progesterone’s mechanisms of action in breast cancer
previous
next
Clinical Trials (Low Cost Interventions)
Tata hospital's simple intervention gives hope to breast cancer patients
Tata hospital's simple intervention gives hope to breast cancer patients
Spearheaded by Badwe, the study was conducted on 1,600 women planning to undergo early breast cancer surgery at 11 cancer centres in India, including TMC, over 11 years from 2011-2022, said Gupta
Tata Memorial’s study suggests simple, low-cost intervention to significantly increase breast cancer cure rate and survival rate
Tata Memorial’s study suggests simple, low-cost intervention to significantly increase breast cancer cure rate and survival rate
Mumbai | September 12, 2022 Dr Rajendra Badwe, Director, Tata Memorial Centre, Mumbai today
Study on over 1,600 patients suggests simple intervention to increase breast cancer cure rates: Director, Tata Memorial Centre - ET HealthWorld
Study on over 1,600 patients suggests simple intervention to increase breast cancer cure rates: Director, Tata Memorial Centre - ET HealthWorld
Tata Memorial Centre: "The trial in women undergoing breast cancer surgery involved the injection of a commonly used drug around the tumour, on the operating table, just before surgery The injection requires no additional expertise, is inexpensive, and can result in saving up to 100,000 lives annually globally. These benefits are substantial and were achieved with an intervention the cost of which was less than Rs 100 per patient," Dr Badwe said.
Low-Cost Local Anaesthesia Can Reduce Breast Cancer Recurrence
Low-Cost Local Anaesthesia Can Reduce Breast Cancer Recurrence
Scientists claim that simple intervention of local anaesthesia can work as an anti-cancer agent if administered before breast cancer surgery.
Tata hospital's low-cost intervention: hope to cancer patients
Tata hospital's low-cost intervention: hope to cancer patients
A clinical trial conducted at the Tata Memorial Centre (TMC) has indicated that a simple, low-cost intervention can drastically increase the cure and survival r
Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access | Cancerworld Magazine
Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access | Cancerworld Magazine
Doctors at the Tata Memorial Hospital in Mumbai have shown that an ultra-low dose of the immunotherapy drug nivolumab significantly improves survival in patients with recurrent or newly diagnosed head and neck cancers. The findings of the single-centre phase III randomised controlled trial are significant because the trial protocol used just 6% of the recommended
Study: 3-month drug therapy for breast cancer sufficient, cheaper - Times of India
Study: 3-month drug therapy for breast cancer sufficient, cheaper - Times of India
Science News: MUMBAI: In a landmark study that will help cut down the cost of drug therapy for breast cancer patients by almost two-thirds, doctors from Tata Memori.
previous
next
Resveratrol RCu Tablet
Tata Memorial Centre Offers Quicker, Safer Whole Breast Reconstruction | Mumbai News - Times of India
Tata Memorial Centre Offers Quicker, Safer Whole Breast Reconstruction | Mumbai News - Times of India
The Tata Memorial Centre in Mumbai now offers a quicker and safer method of whole breast reconstruction for breast cancer patients. The new technique
Dying cancer cells, at times, trigger new tumours, say Tata doctors | Mumbai News - The Times of India
Dying cancer cells, at times, trigger new tumours, say Tata doctors | Mumbai News - The Times of India
CSR Activities
Game changer in cancer care: Tata hospital to unveil world’s largest nuclear therapeutic facility
Game changer in cancer care: Tata hospital to unveil world’s largest nuclear therapeutic facility
ACTREC–Kharghar to begin initiative in 2-3 months